4592.T
SanBio Company Limited
グロース · 医薬品 · 医薬品 · JP
JPY 910.00
+0.33%Income statement
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | — | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | — | — | — | — | — |
| Cost and Expenses | — | — | — | — | — |
| Operating Income (EBIT) | (3.8B) | (3.8B) | (3.5B) | (4.5B) | (7.9B) |
| Non-Operating | |||||
| Interest Income | 6.5M | 6.5M | 2.4M | 2.5M | 4.0M |
| Interest Expense | 5.8M | 5.8M | 8.3M | 10.5M | 25.3M |
| Net Interest Income | 652.0K | 652.0K | (5.9M) | (8.1M) | (21.3M) |
| Other Non-Op Income/Expense | (496.9M) | (496.9M) | 493.7M | 1.7B | 3.2B |
| Non-Operating Income (excl Interest) | 79.0K | 79.0K | 625.2M | 1.8B | 3.3B |
| EBT (Pre-Tax Income) | (4.3B) | (4.3B) | (3.0B) | (2.5B) | (4.7B) |
| Income Tax Expense | (449.1M) | (449.1M) | (127.8M) | 102.2M | 862.1M |
| Bottom Line | |||||
| Net Income | (3.8B) | (3.8B) | (2.9B) | (2.6B) | (5.6B) |
| Earnings from Cont. Ops | — | — | — | — | — |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (3.8B) | (3.8B) | (2.9B) | (2.6B) | (5.6B) |
| Per Share | |||||
| Basic EPS | (¥53) | (¥53) | (¥42) | (¥40) | (¥96) |
| Diluted EPS | (¥53) | (¥53) | — | — | — |
| Revenue Per Share | — | — | — | — | — |
| Shares | |||||
| Basic Shares Outstanding | 73.1M | 73.1M | 68.9M | 65.3M | 57.9M |
| Diluted Shares Outstanding | — | — | — | — | — |
| Profitability Metrics | |||||
| EBITDA | (2.0B) | (3.8B) | (3.5B) | (4.5B) | (7.9B) |
| D&A | 8.1M | 8.1M | 9.4M | 14.5M | 24.6M |
| EBIT | (3.8B) | (3.8B) | (3.5B) | (4.5B) | (7.9B) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jan 1, 2026